tadalafil has been researched along with Gastric Ulcer in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Abo-Saif, AA; Alghamdi, BS; Elkomy, MH; Mohamed, WR; Mohamed, YT; Naguib, IA | 1 |
Allam, AN; Domiati, S; Mehanna, MM; Mneimneh, AT | 1 |
Abd Al Haleem, EN; Arafa, HMM; Ibrahim, FAM; Zaytoon, SAB | 1 |
3 other study(ies) available for tadalafil and Gastric Ulcer
Article | Year |
---|---|
Role of ADMA/DDAH-1 and iNOS/eNOS signaling in the gastroprotective effect of tadalafil against indomethacin-induced gastric injury.
Topics: Amidohydrolases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arginine; Indomethacin; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Prostaglandins E; Quality of Life; Rats; Stomach Ulcer; Tadalafil; Ulcer | 2022 |
Tadalafil-Loaded Limonene-Based Orodispersible Tablets: Formulation, in vitro Characterization and in vivo Appraisal of Gastroprotective Activity.
Topics: Administration, Oral; Animals; Drug Compounding; Drug Delivery Systems; Emulsions; Freeze Drying; Hardness; Limonene; Male; Porosity; Protective Agents; Rats, Wistar; Solubility; Stomach; Stomach Ulcer; Tablets; Tadalafil; Thermodynamics; Water | 2020 |
Possible protective effect of TNF-α inhibition and triad NO/cGMP/VEGF activation on gastric ulcer in rats.
Topics: Animals; Cyclic GMP; Dinoprostone; Indomethacin; Male; Malondialdehyde; Nitric Oxide; Pentoxifylline; Rats; Stomach Ulcer; Tadalafil; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2021 |